Nutrition on a GLP-1 can be highly individualized, so its always a good idea to talk to your doctor or dietitian about what makes the most sense for you
Taken together, these structural, conceptual, and terminological issues expose a broader problem: the ATC system is not merely outdated, it is ill-suited to represent todays pharmacotherapy
Researched effects In a diet-induced-obese mouse study (Neelakantan et al., Biochemical Pharmacology, 2018), subcutaneous 5-Amino-1MQ (20 mg/kg, three times daily, roughly 11 days) produced about 5.1% body-weight loss versus continued weight gain in untreated controls, roughly 35% less epididymal white fat mass, smaller adipocytes, lower plasma cholesterol, and improved glucose tolerance, with no reported change in food intake and no observed adverse effects in the mice
This is especially true during the early period after starting semaglutide and during dose escalation phases